openPR Logo
Press release

Inactivated Vaccines Market is Fueled by Expanding Immunization Programs 2025-2033 | Pfizer Inc., Serum Institute of India Pvt. Ltd., GSK plc., Sanofi., Merck & Co., Inc., Bharat Biotech

07-08-2025 12:28 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Inactivated Vaccines Market

Inactivated Vaccines Market

The Global Inactivated Vaccines Market reached US$ 22.60 billion in 2024 and is expected to reach US$ 34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032.

The latest Inactivated Vaccines Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/inactivated-vaccines-market?ophp

Inactivated vaccines contain viruses or bacteria that have been killed so they can't cause disease but still trigger a protective immune response. Immunization campaigns and greater public health focus are fueling market growth, particularly in Asia-Pacific and Latin America.

Inactivated Vaccines Market Competitors Overview:

Serum Institute of India Pvt. Ltd., GSK plc., Sanofi., Biological E Limited., Bharat Biotech., Bio Farma, Merck & Co., Inc., Valneva SE., Pfizer Inc., and KM Biologics among others.

Important Industry Updates of 2024 and 2025:

✅ In June 2024, Sanofi announced a partnership with Biovac to start local manufacturing of inactivated polio vaccines (IPV) in Africa. This partnership enables polio vaccine supply to more than 40 African countries in the future and also supports the Africa CDC goal to have 60% of local vaccine production goal by 2040.

✅ In April 2024, the World Health Organization (WHO) provided prequalification for new oral inactivated cholera vaccine Euvichol-S. This prequalification adds the third product to the list of oral inactivated cholera vaccines produced by EuBiologicals Co.Ltd.

Inactivated Vaccines Market Segments Overview:

∎By Pathogen (Bacteria and Virus)
∎By Vaccine Type (Polio Vaccine, DTaP Vaccine, Influenza Vaccine, Hepatitis Vaccine, Japanese Encephalitis Vaccine, Rabies Vaccine, Cholera Vaccine, and Others)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/inactivated-vaccines-market?ophp

Methodology and Scope:

This Inactivated Vaccines Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Inactivated Vaccines Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=inactivated-vaccines-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➤ What are the global sales, production, import, and export trends in the Inactivated Vaccines market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Inactivated Vaccines market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inactivated Vaccines Market is Fueled by Expanding Immunization Programs 2025-2033 | Pfizer Inc., Serum Institute of India Pvt. Ltd., GSK plc., Sanofi., Merck & Co., Inc., Bharat Biotech here

News-ID: 4095663 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Agave Syrup Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Agave Syrup Market 2025 | Growth Drivers, Key Players & Investment …
Market Size and Growth The Global Agave Syrup Market size USD 643.48 million in 2022 and is projected to witness lucrative growth by reaching up to USD 1,039.88 million by 2030. The market is growing at a CAGR of 6.3% during the forecast period (2024-2031). Key Development: ✅ In 2025, the U.S. market shows strong demand from plant-based diets and health-driven consumer behavior: usage in beverages up ~39%, in bakery ~32%, and confectionery
United States Vegan Cheese Market 2025 | Rising Demand, Innovation & Market Expansion Trends
United States Vegan Cheese Market 2025 | Rising Demand, Innovation & Market Expa …
Market Size and Growth Vegan Cheese Market is predicted to reach a CAGR of 15% during the forecast period (2024-2031). Key Development: United States: Recent Industry Developments ✅ In May 2025, Daiya introduced its first-to-market dairy-free cream cheese packets (1-oz) specifically for foodservice operators, aiming to meet demand for portable and convenient plant-based cream cheese options. ✅ In March 2025, New Culture secured over US$5 million in early demand from pizza chefs and restaurant operators
United States Vegan Eggs Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Vegan Eggs Market 2025 | Growth Drivers, Key Players & Investment …
Market Size and Growth The Global Vegan Eggs Market reached US$ 1.5 billion in 2022 and is expected to reach US$ 4.5 billion by 2030 and grow with a CAGR of 14.8% during the forecast period 2024-2031. The consumption of meat and animal products decreased due to the fear of diseases. Key Development: United States: Recent Vegan Egg Developments ✅ In August 2025, UK startup Plant Heads launched its vegan liquid egg "Crackd"
United States Biologics Contract Manufacturing Market Accelerates with Growing Biopharma Outsourcing and Need for Scalable Production | Key Players: Wuxi Biologics, AGC Biologics, Lonza, FUJIFILM Diosynth Biotechnologies
United States Biologics Contract Manufacturing Market Accelerates with Growing B …
Outsourced biologics manufacturing including monoclonal antibodies (mAbs), vaccines, and advanced therapies such as cell and gene treatments has become essential to driving biopharma innovation. According to DataM Intelligence, the global biologics contract manufacturing market was valued at USD 26.03 billion in 2024 and is projected to reach USD 83.47 billion by 2033, expanding at a CAGR of 14.0% between 2025 and 2033. Download exclusive insights with our detailed sample report (Corporate

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion